Drdgold Stock Current Valuation
Valuation analysis of Drdgold helps investors to measure Drdgold's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Drdgold Company Current Valuation Analysis
Drdgold's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Drdgold Current Valuation | 433.63 M |
Most of Drdgold's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Drdgold is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Drdgold has a Current Valuation of 433.63 M. This is 96.2% lower than that of the Basic Materials sector and 88.97% lower than that of the Gold industry. The current valuation for all United States stocks is 97.39% higher than that of the company.
Drdgold Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Drdgold's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Drdgold could also be used in its relative valuation, which is a method of valuing Drdgold by comparing valuation metrics of similar companies.Drdgold is currently under evaluation in current valuation category among its peers.
Drdgold Fundamentals
| Return On Equity | 0.22 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.22 % | |||
| Operating Margin | 0.24 % | |||
| Current Valuation | 433.63 M | |||
| Shares Outstanding | 857.98 M | |||
| Shares Owned By Insiders | 50.23 % | |||
| Shares Owned By Institutions | 10.67 % | |||
| Price To Earning | 0.59 X | |||
| Price To Book | 1.58 X | |||
| Price To Sales | 0.11 X | |||
| Revenue | 5.12 B | |||
| Gross Profit | 1.38 B | |||
| EBITDA | 1.8 B | |||
| Net Income | 1.12 B | |||
| Cash And Equivalents | 2.53 B | |||
| Cash Per Share | 29.44 X | |||
| Total Debt | 52.3 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 4.92 X | |||
| Book Value Per Share | 63.40 X | |||
| Cash Flow From Operations | 1.5 B | |||
| Earnings Per Share | 0.07 X | |||
| Number Of Employees | 943 | |||
| Beta | 1.19 | |||
| Market Capitalization | 674.43 M | |||
| Total Asset | 7.08 B | |||
| Retained Earnings | (2.98 B) | |||
| Working Capital | 287 M | |||
| Current Asset | 601 M | |||
| Current Liabilities | 314 M | |||
| Z Score | 7.2 | |||
| Annual Yield | 0.05 % | |||
| Net Asset | 7.08 B | |||
| Last Dividend Paid | 6.0 |
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in Drdgold Pink Sheet
If you are still planning to invest in Drdgold check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Drdgold's history and understand the potential risks before investing.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |